 Krista Eschbach
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsies, Myoclonic | 4 | 2020 | 41 | 1.940 |
Why?
| | Epilepsy | 8 | 2023 | 278 | 1.220 |
Why?
| | Drug Resistant Epilepsy | 6 | 2023 | 45 | 1.130 |
Why?
| | Anticonvulsants | 3 | 2021 | 178 | 0.880 |
Why?
| | Neurology | 1 | 2021 | 85 | 0.690 |
Why?
| | Seizures | 9 | 2023 | 337 | 0.670 |
Why?
| | Patient Admission | 1 | 2021 | 175 | 0.660 |
Why?
| | Dioxolanes | 1 | 2019 | 6 | 0.650 |
Why?
| | Developmental Disabilities | 2 | 2020 | 236 | 0.620 |
Why?
| | Brain Waves | 1 | 2018 | 20 | 0.610 |
Why?
| | Nervous System Diseases | 1 | 2021 | 254 | 0.600 |
Why?
| | Patient Safety | 1 | 2021 | 273 | 0.600 |
Why?
| | Electroencephalography | 6 | 2021 | 359 | 0.580 |
Why?
| | Thyrotropin | 1 | 2017 | 100 | 0.560 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 286 | 0.490 |
Why?
| | Epileptic Syndromes | 3 | 2021 | 66 | 0.480 |
Why?
| | Testosterone | 1 | 2017 | 341 | 0.460 |
Why?
| | Telemedicine | 1 | 2021 | 662 | 0.420 |
Why?
| | Seizures, Febrile | 2 | 2021 | 19 | 0.360 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1815 | 0.360 |
Why?
| | Child | 14 | 2023 | 18401 | 0.270 |
Why?
| | Child, Preschool | 8 | 2023 | 9114 | 0.230 |
Why?
| | Psychosurgery | 1 | 2023 | 5 | 0.230 |
Why?
| | Diet, Ketogenic | 2 | 2021 | 33 | 0.220 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 253 | 0.210 |
Why?
| | Genetic Testing | 2 | 2022 | 381 | 0.200 |
Why?
| | Status Epilepticus | 2 | 2021 | 32 | 0.200 |
Why?
| | Laser Therapy | 1 | 2023 | 99 | 0.200 |
Why?
| | Infant | 6 | 2022 | 7943 | 0.200 |
Why?
| | GABA Modulators | 1 | 2021 | 7 | 0.190 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2019 | 15 | 0.190 |
Why?
| | Cerebral Palsy | 1 | 2022 | 80 | 0.180 |
Why?
| | Spasms, Infantile | 1 | 2021 | 103 | 0.170 |
Why?
| | Encephalitis | 1 | 2021 | 126 | 0.160 |
Why?
| | Retrospective Studies | 8 | 2023 | 12521 | 0.160 |
Why?
| | Drug Approval | 1 | 2019 | 78 | 0.160 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2018 | 16 | 0.150 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 4402 | 0.150 |
Why?
| | Humans | 18 | 2023 | 114045 | 0.150 |
Why?
| | Cohort Studies | 4 | 2020 | 4883 | 0.140 |
Why?
| | Body Height | 1 | 2017 | 180 | 0.130 |
Why?
| | Male | 7 | 2022 | 55396 | 0.120 |
Why?
| | Mutation | 3 | 2021 | 3338 | 0.110 |
Why?
| | Quality Improvement | 1 | 2021 | 944 | 0.110 |
Why?
| | Female | 7 | 2022 | 59324 | 0.110 |
Why?
| | Body Weight | 1 | 2017 | 868 | 0.110 |
Why?
| | Adolescent | 5 | 2023 | 17800 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2023 | 9049 | 0.080 |
Why?
| | Risk Factors | 1 | 2021 | 8614 | 0.070 |
Why?
| | Young Adult | 2 | 2022 | 10444 | 0.070 |
Why?
| | Adult | 3 | 2023 | 30375 | 0.070 |
Why?
| | Middle Aged | 2 | 2022 | 26605 | 0.060 |
Why?
| | Corpus Callosum | 1 | 2023 | 56 | 0.050 |
Why?
| | Probability | 1 | 2023 | 286 | 0.050 |
Why?
| | Subdural Space | 1 | 2021 | 6 | 0.050 |
Why?
| | Animals | 2 | 2021 | 31565 | 0.050 |
Why?
| | Stereotaxic Techniques | 1 | 2021 | 29 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2022 | 5038 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 249 | 0.050 |
Why?
| | Prospective Studies | 2 | 2023 | 6195 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 128 | 0.050 |
Why?
| | Infectious Encephalitis | 1 | 2020 | 1 | 0.050 |
Why?
| | Electrodes, Implanted | 1 | 2021 | 91 | 0.050 |
Why?
| | Immune System Diseases | 1 | 2021 | 32 | 0.050 |
Why?
| | Potassium Channels | 1 | 2021 | 121 | 0.050 |
Why?
| | Valproic Acid | 1 | 2020 | 43 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 146 | 0.040 |
Why?
| | Cannabinoids | 1 | 2021 | 115 | 0.040 |
Why?
| | Cannabidiol | 1 | 2021 | 60 | 0.040 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 7 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 23 | 0.040 |
Why?
| | Databases, Factual | 1 | 2023 | 1125 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 35 | 0.040 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 43 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2021 | 348 | 0.040 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 82 | 0.040 |
Why?
| | Family Health | 1 | 2019 | 193 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 205 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 926 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 527 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 2784 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1311 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2343 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 4595 | 0.020 |
Why?
|
|
Eschbach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|